Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Nowadays vaccination of the population living in the endemic regions and widespread implementation of the potent therapies for the emergency prophylaxis and treatment into the clinical practice are regarded as the basic efficient and cost-effective measures for Ebola epidemic spread control. Objecti...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	A. A. Petrov, V. N. Lebedev, T. M. Plekhanova, L. F. Stovba, G. V. Borisevich, O. N. Sidorova, O. V. Chukhralya, S. V. Borisevich
التنسيق:	مقال
اللغة:	Russian
منشور في:	Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2015-09-01
سلاسل:	Проблемы особо опасных инфекций
الموضوعات:	вирус эбола лекарственные средства экстренная профилактика и лечение вирусспецифические антитела моноклональные антитела малые интерферирующие рнк антисмысловые фосфордиамидатные морфолиновые олигомеры ebola virus hemorrhagic fever medical products emergency prophylaxis and treatment virus-specific antibodies monoclonal antibodies small interfering rna anti-sense phosphordiamidate morpholine oligomers
الوصول للمادة أونلاين:	https://journal.microbe.ru/jour/article/view/254

مواد مشابهة

Monoclonal Antibodies and Recombinant Proteins for Immune-Diagnostics of Ebola Virus Disease
حسب: E. I. Kazachinskaya, وآخرون
منشور في: (2015-09-01)

“CAMEL” ANTIBODIES: FEATURES OF THEIR STRUCTURE, PREPARATION AND APPLICATION
حسب: Alexey Alekseevich Andreev, وآخرون
منشور في: (2020-06-01)

Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases
حسب: A. A. Petrov, وآخرون
منشور في: (2020-05-01)

New Monoclonal Antibodies for the Diagnosis of Influenza and other Acute Respiratory Viral Infections
حسب: A. A. Sominina, وآخرون
منشور في: (2015-10-01)

Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
حسب: A. V. Philippova, وآخرون
منشور في: (2019-10-01)

Preparations of next generation monoclonal antibodies (issues and prospects)
حسب: Zh. I. Avdeeva, وآخرون
منشور في: (2018-02-01)

SMALL NONCODING RNA AS PERSPECTIVE BIOMARKERS: BIOGENESIS AND THERAPEUTIC STRATIGIES
حسب: V. V. Tiguntsev, وآخرون
منشور في: (2016-06-01)

Obtainment of Monoclonal Antibodies and Prospects of Their Application as Basis for Immunodiagnostic Aids for Crimean-Congo Hemorrhagic Fever Virus Detection
حسب: N. P. Khrapova, وآخرون
منشور في: (2015-03-01)

Safety issues of monoclonal antibodies used in rheumatology
حسب: A. V. Philippova, وآخرون
منشور في: (2020-01-01)

The Molecular Genetic Peculiarities of Genomic Structure of Members of the <i>Ebolavirus</i> Genus
حسب: A. A. Petrov, وآخرون
منشور في: (2015-09-01)

Manufacturing of Hybridomas-Producers of Monoclonal Anti-Bodies to Tularemia Agent Antigens
حسب: O. O. Fomenkov, وآخرون
منشور في: (2015-06-01)

Study of protectivity and antigenicity of vaccine based on ' cultural Asia-1 No.2145/ Tajikistan/2011 FMD Virus
حسب: D. A. Lozovoy, وآخرون
منشور في: (2018-04-01)

Constructing and Medical Trials of a Monoclonal Dot-Immuno-Enzyme Test-System “DIATul-M” for Tularemia Microbe Detection
حسب: N. E. Tereshkina, وآخرون
منشور في: (2013-06-01)

SEROPREVALENCE OF INFECTIOUS BURSAL DISEASE VIRUS IN PRIVATE POULTRY BREEDINGS OF UKRAINE FROM 2014 TO 2016
حسب: А. С. Пастиря, وآخرون
منشور في: (2017-06-01)

Utilization of Immunoblotting in Studies of Epitope Targeting in Monoclonal Antibodies to Melioidosis Agent Antigen 200 kDa
حسب: I. I. Korsakova, وآخرون
منشور في: (2014-12-01)

Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease
حسب: T. E. Sizikova, وآخرون
منشور في: (2015-09-01)

Diagnosis of hepatitis c today and interpretation of infection markers
حسب: T. V. Kozhanova
منشور في: (2013-12-01)

Antidiphtheria immunity at children with allergic diseases
حسب: A V Labushkina, وآخرون
منشور في: (2009-12-01)

Pharmacokinetic properties of the preparations of protein origin
حسب: A. A. Soldatov, وآخرون
منشور في: (2018-02-01)

Development of Immune-Chromatographic Monoclonal Test-System for the Detection of <i>Yersinia pseudotuberculosis</i>, Serogroup I
حسب: N. V. Bogacheva, وآخرون
منشور في: (2016-06-01)

Validation of the technique aimed at the determination of FMD antibodies in liquid phase blocking sandwich Elisa
حسب: N. N. Lugovskaya, وآخرون
منشور في: (2018-04-01)

Возможности сочетания иммунотерапии с лучевой терапией в лечении больных неоперабельным местно-распространённым немелкоклеточным раком легкого. Обзор литературы.
منشور في: (2021-06-01)

Сравнительная эффективность и безопасность применения препаратов моноклональных антител к ИЛ-6 у пациентов с новой коронавирусной инфекцией COVID-19 тяжелого течения. Ретроспективное когортное исследование
حسب: С. С. Бобкова, وآخرون
منشور في: (2021-03-01)

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review
حسب: D. L. Klabukova, وآخرون
منشور في: (2018-07-01)

Метод РНК-интерференции в защите растений от насекомых-вредителей
حسب: Владимир Сергеевич Журавлев, وآخرون
منشور في: (2022-04-01)

Validation of the XTT-test for assessing the antiproliferative activity of biologics on the basis of monoclonal antibodies
حسب: I. V. Lyagoskin, وآخرون
منشور في: (2018-02-01)

FREQUENCY OF OCCURRENCE OF ANTIBODIES TO HLA ANTIGENS IN RECIPIENTS ON THE WAITING LIST FOR KIDNEY TRANSPLANTATION
حسب: Елена Борисовна Лукоянычева, وآخرون
منشور في: (2023-02-01)

The morphological changes dynamics of ovarian reproductive apparatus in the experimental autoimmune oophoritis
حسب: M. L. Dmitriyeva, وآخرون
منشور في: (2012-02-01)

The Value of the Effect of the Level of Specific Antibodeis on Elimination Different Tick-Borne Encephalitis Virus Strains
حسب: G. N. Leonova, وآخرون
منشور في: (2017-04-01)

Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development
حسب: A. A. Lidzhieva, وآخرون
منشور في: (2018-02-01)

The State of Specific Immunity to Measles and Rubella Virus in Newborns and their mothers
حسب: N. T. Tikhonova, وآخرون
منشور في: (2017-12-01)

Construction and Investigation of the Variants of the Vaccine Strain <I>Francisella tularensis</I> Lacking <I>iglC </I>Genes. Communication 2
حسب: A. N. Mokrievich, وآخرون
منشور في: (2013-12-01)

Donor – recipient selection using epitope mismatches in kidney transplantation
حسب: A. V. Vatazin, وآخرون
منشور في: (2021-01-01)

Improvement of Diagnostic System in a Real-Time RT-PCR “AmpliSens EBOV (ZAIRE)-FL” Format for Zaire ebolavirus RNA Detection
حسب: V. G. Dedkov, وآخرون
منشور في: (2015-09-01)

Construction and Approval of the Test-System for the Detection of Antibodies to Anthrax Agent Using Indirect Fluorescent Immunoassay
حسب: L. Yu. Aksenova, وآخرون
منشور في: (2013-12-01)

Antikeratin antibodies in rheumatoid arthritis
حسب: J Zabek
منشور في: (2003-02-01)

Заболявания, свързани с анти-миелинови олигодендроцитни гликопротеинови антитела (MOG-antibody diseases)
حسب: Sonia Ivanova, وآخرون
منشور في: (2019-09-01)

The possible role of toxoplasmosis in the development of antiphospholipid antibodies in pregnancy-related complications
حسب: - Bayati Ali Hattem Hussein, وآخرون
منشور في: (2012-09-01)

Studies of Ebola Virus persistence in the Body Fluids of a Patient at Advanced Stages of Convalescence
حسب: A. A. Lopatin, وآخرون
منشور في: (2015-09-01)

Future Developments and Applications of the Vaccines against Dangerous Viral Infections, RNA-Replicon-Based, Obtained from the Venezuelan Equine Encephalomyelitis Virus
حسب: A. A. Petrov, وآخرون
منشور في: (2014-09-01)